Viewing Study NCT05598268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-01-28 @ 2:43 PM
Study NCT ID: NCT05598268
Status: UNKNOWN
Last Update Posted: 2022-10-28
First Post: 2022-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
Sponsor: ImmVira Pharma Co. Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Lung Cancer View
None Liver Cancer View
None Lymphoma View
None Mesothelioma of Pleura View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Herpes virus View
None Advanced solid tumor View
None Dose escalation View
None T3011 View
None Oncolytic virus View